## ALB: Albemarle Corporation - XLB: Basic Materials

### Executive Summary

PARABOLIC warning: MRS_20 at 10.7% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops. Caution: declining volume (46% of avg), momentum weakening (-2.1% MRS).

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($138.20)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Albemarle stock hits 52-week high at $151.00**
- Source: Investing.com | 20251226T140740 | Bullish | Relevance: 100%
- Albemarle Corp’s stock reached a new 52-week high of $151.00, marking a significant upward trend with a 70.04% appreciation over the past year and a 134.93% surge in six months. This performance reflects strong investor confidence, though InvestingPro analysis suggests the stock is currently trading slightly above its Fair Value and is in overbought territory. Recent developments include adjusted EBITDA forecasts from Morgan Stanley, a raised price target from Truist Securities, and a cesium concentrate offtake agreement, all contributing to the company's strategic maneuvers.

**2. Albemarle (ALB) Monthly Analysis: Lithium Recovery & 2030 Roadmap**
- Source: openPR.com | 20251225T200758 | Somewhat-Bullish | Relevance: 100%
- Albemarle Corporation (ALB) is navigating lithium market volatility with its "Vision 2030" strategy, aiming to leverage low-cost assets and expanded refining capacity for long-term growth. Despite current stock consolidation and commodity price sensitivity, the company expects a recovery fueled by narrowing lithium surpluses and surging EV demand, potentially retesting its all-time high by 2030 through strategic capital discipline and integrated production. The analysis highlights ESG leadership, energy storage growth, and global scale as key drivers for ALB's future.

**3. Has Albemarle’s 74% Rally in 2025 Already Priced In Its Lithium Recovery Story?**
- Source: Simply Wall Street | 20251225T020919 | Neutral | Relevance: 100%
- Albemarle (NYSE: ALB) has seen a significant rally in 2025 with a 74.2% year-to-date increase, driven by shifting expectations for lithium demand. Despite this, a Discounted Cash Flow (DCF) analysis suggests it's only about 4.8% overvalued, while a Price to Sales (PS) ratio of 3.53x indicates it's overvalued compared to industry averages and its own Fair Ratio of 1.28x. The article explores these valuation methods, noting that while the rally suggests optimism, fundamental analysis presents a mixed picture.

**4. Greenwood Capital Associates LLC Buys Shares of 50,156 Albemarle Corporation $ALB**
- Source: MarketBeat | 20251227T133254 | Somewhat-Bullish | Relevance: 100%
- Greenwood Capital Associates LLC has acquired a new position of 50,156 shares in Albemarle Corporation (NYSE:ALB) during the third quarter, valued at approximately $4.07 million. Institutional investors and hedge funds now collectively own about 92.87% of the specialty chemicals company's stock. Albemarle recently surpassed Q3 EPS estimates and announced a quarterly dividend of $0.405, while analysts maintain an average "Hold" rating for the stock with a target price below its current trading level.

**5. Albemarle stock hits 52-week high at $151.00 By Investing.com**
- Source: Investing.com Nigeria | 20251226T143820 | Bullish | Relevance: 100%
- Albemarle Corporation's stock has reached a new 52-week high of $151.00, reflecting a 70.04% appreciation over the past year and a 134.93% surge in the last six months. This strong performance comes amidst analyst upgrades and strategic corporate developments, including a cesium concentrate offtake agreement, despite the company not being profitable over the last twelve months and its stock trading slightly above its Fair Value.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $135 | $100 | +35% |
| 2025-12-18 | Citigroup | $150 | $100 | +50% |
| 2025-12-18 | Mizuho | $132 | $110 | +20% |
| 2025-12-05 | UBS | $185 | $107 | +73% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | main | Equal-Weight |
| 2025-12-18 | Citigroup | main | Neutral |
| 2025-12-18 | Mizuho | main | Neutral |
| 2025-12-05 | UBS | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital World Invest: 7.0% (+0.2%)
- Blackrock Inc.: 7.0% (-0.1%)
- State Street Corpora: 4.8% (-15.4%)
- Franklin Resources, : 2.8% (-42.8%)

### Key Risks

1. Valuation stretched: PEG 20.8x requires aggressive growth execution.
2. Elevated short interest (12.5%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +39%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 20.83 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (6 raises, avg +39%). Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $17.7B |
| Beta | 1.43 |
| 52W Range | $49.43 - $152.08 |
| Short Interest | 12.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 20.83 |
| Forward P/E | 138.7 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 12.8% to 10.7% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Extended beyond STRENGTH zone (10.7% > 10.0%), caution on chasing. MRS_5 at 1.4% confirms short-term momentum alignment. AM_20 at 11.7% shows strong absolute momentum above own 20MA. Outperforming sector by 8.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.89), confirming momentum. RSI overbought at 76, risk of mean reversion. Volume at 46% of 20MA suggests lack of conviction. OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 10.69% (CS: 99) | Strong |
| RSI_14 | 76.2 | Overbought |
| MACD Histogram | 0.89 | Bullish |
| vs SMA20 | 1.116x | Above |
| vs SMA50 | 1.288x | Above |
| vs SMA200 | 1.826x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $150.02
- **Stop Loss:** $138.20 (7.9% risk)
- **Target:** $161.84 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 111
- **Position Value:** $16,652.22
- **Portfolio %:** 16.65%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-11 (Est: $-0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.88 | $-0.19 | +78.3% |
| 2025Q2 | $-0.81 | $0.11 | +113.5% |
| 2025Q1 | $-0.68 | $-0.18 | +73.5% |
| 2024Q4 | $-0.67 | $-1.09 | -63.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*